Brief: Transcode Therapeutics Announces 1-For-20 Reverse Stock Split
22/05/2023 12:44
May 22 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES 1-FOR-20 REVERSE STOCK
SPLIT
* TRANSCODE THERAPEUTICS INC - COMMON STOCK IS EXPECTED TO
BEGIN
TRADING ON SPLIT-ADJUSTED BASIS ON NASDAQ CAPITAL MARKET ON
TUESDAY, MAY 23
Source text for Eikon: ID:nGNXMSF7x
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors